Insider trades
Schorno Dean L., CFO of Rigel Pharmaceuticals RIGL, has filed 0 purchases and 5 sales on the open market. The latest trade was on 06/17.
Schorno Dean L.
EVP & CFO
- Company
- Rigel Pharmaceuticals RIGL
- First filing
- 23/01/30
- Trades
- 34 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
RIGL | Open-market sale | 25/02/04–25/02/05 | 25/02/06 | 3,770 sh2 trades | $21.38avg. | $80,619.74 | −6.2% |
RIGL | Open-market sale | 24/02/02–24/02/05 | 24/02/06 | 12,628 sh2 trades | $1.14avg. | $14,339.91 | −3.0% |
| Open-market sale | 23/02/02 | 23/02/06 | 5,389 sh | $1.66 | $8,945.74 | −2.7% |